Show Stocks and Investing Publications • Mon, September 9, 2024
Vamil Divan Upgraded (TVTX) to Strong Buy and Held Target at $25 on, Sep 9th, 2024
divan-upgraded-tvtx-to-strong-buy-and-held-target-at-25-on-sep-9th-2024.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIVamil Divan of Guggenheim, Upgraded "Travere Therapeutics, Inc." (TVTX) to Strong Buy and Held Target at $25 on, Sep 9th, 2024.
Vamil has made no other calls on TVTX in the last 4 months.
There are 7 other peers that have a rating on TVTX. Out of the 7 peers that are also analyzing TVTX, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024
These are the ratings of the 6 analyists that currently disagree with Vamil
- Carly Kenselaar of "Citigroup" Maintained at Strong Buy with Increased Target to $23 on, Friday, September 6th, 2024
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $23 on, Friday, September 6th, 2024
- Greg Harrison of "B of A Securities" Maintained at Strong Buy with Increased Target to $19 on, Friday, September 6th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $20 on, Tuesday, August 13th, 2024
- Carter Gould of "Barclays" Maintained at Buy with Increased Target to $14 on, Friday, August 2nd, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024
Like: 👍